HighGravityData

Eastman Chemical — Nov 3, 2025 release

Fiscal 2025 third-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0000915389-25-000176
Open on SEC.gov ↗
Showing in the filing
Sales volume (seasonal decline)
“greater than normal seasonal decline in volume”
Period
Q4 FY2025
Measure
Company-defined measure
Source
Prose
All guidance in this release · 8
Sales volume (seasonal decline) for Q4 FY2025
“greater than normal seasonal decline in volume”
Revenue from Kingsport methanolysis facility for FY2025
“a modest increase in revenue”
Cost reduction for FY2025
“more than $75 million, net of inflation”
Cost structure reduction, net of inflation for FY2025
“more than $75 million”
Additional structural cost reduction, net of… for FY2026
“approximately $100 million”
Structural costs reduction for FY2026
“approximately $100 million, net of inflation”
Adjusted earnings per share for FY2025
“between $5.40 and $5.65”
Operating cash flow for FY2025
“approach $1 billion”
Exhibit 99.1 · the passage around this item
… earlier in the release
Priorities for uses of available cash include capital expenditures, payment of the quarterly dividend, and net debt reduction. 2025 Outlook Commenting on the outlook for fourth-quarter and full-year 2025, Costa said: “We expect a greater than normal seasonal decline in volume as the macroeconomic environment continues to be challenging, especially in the consumer discretionary markets (building and construction, consumer durables and auto aftermarket). We see signs of increasing consumer caution, including value-oriented trade-down behavior. Our customers through the retailers are also continuing to unwind inventory purchased and prepositioned geographically in the first half of the year to mitigate tariff risks and reduce the impact on consumer prices. We do expect most of this pre-buy inventory to be depleted by end of year. "Against this dynamic backdrop, we remain focused on controlling what we can, including driving cash flow. We delivered strong cash flow in the third quarter with our inventory actions and aggressive cost management. We expect price-cost stability, as our commercial teams continue to demonstrate excellence in defending our prices and market share, based on the innovative value of our products. We also expect a modest increase in revenue from the Kingsport methanolysis facility. We are on track to reduce costs by more than $75 million, net of inflation, and also plan to build on this progress by reducing structural costs by approx
later in the release …
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.